Effects of vitamin E supplementation on the risk and progression of AD: a systematic review and meta-analysis

References

• Pfeifer LA, White LR, Ross GW, Petrovitch H, Launer LJ. Cerebral amyloid angiopathy and cognitive function: the HAAS autopsy study. Neurology. 2002;58(11):1629–34. PubMed PMID: 12058090. doi: 10.1212/WNL.58.11.1629
   PubMed Web of Science ®Google Scholar
• Yatin SM, Yatin M, Aulick T, Ain KB, Butterfield DA. Alzheimer’s amyloid beta-peptide associated free radicals increase rat embryonic neuronal polyamine uptake and ornithine decarboxylase activity: protective effect of vitamin E. Neurosci Lett. 1999;263(1):17–20. PubMed PMID: 10218900. doi: 10.1016/S0304-3940(99)00101-9
   PubMed Web of Science ®Google Scholar
• Gemma C, Vila J, Bachstetter A, Bickford PC. Oxidative stress and the aging brain: from theory to prevention. In: Riddle DR, editor. Brain aging: models, methods, and mechanisms. Boca Raton (FL): Frontiers in Neuroscience; 2007. p. 1539–1550.
   Google Scholar
• Squier TC. Oxidative stress and protein aggregation during biological aging. Exp Gerontol. 2001;36(9):1539–50. PubMed PMID: 11525876. doi: 10.1016/S0531-5565(01)00139-5
   PubMed Web of Science ®Google Scholar
• Hamley IW. The amyloid beta peptide: a chemist’s perspective. role in Alzheimer’s and fibrillization. Chem Rev. 2012;112(10):5147–92. doi:10.1021/cr3000994. PubMed PMID: 22813427.
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–6. doi:10.1126/science.1072994. PubMed PMID: 12130773.
   PubMed Web of Science ®Google Scholar
• Querfurth HW, LaFerla FM. Alzheimer’s disease. N Engl J Med. 2010;362(4):329–44. doi:10.1056/NEJMra0909142. PubMed PMID: 20107219.
   PubMed Web of Science ®Google Scholar
• Butterfield DA. The 2013 SFRBM discovery award: selected discoveries from the Butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment. Free Radical Biol Med. 2014;74:157–74. doi:10.1016/j.freeradbiomed.2014.06.006. PubMed PMID: 24996204; PubMed Central PMCID: PMC4146642.
   PubMed Web of Science ®Google Scholar
• Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Logroscino G, Santamato A, et al. Immunotherapy for Alzheimer’s disease: from anti-beta-amyloid to tau-based immunization strategies. Immunotherapy. 2012;4(2):213–38. doi:10.2217/imt.11.170. PubMed PMID: 22339463.
   PubMed Web of Science ®Google Scholar
• Ganguly G, Chakrabarti S, Chatterjee U, Saso L. Proteinopathy, oxidative stress and mitochondrial dysfunction: cross talk in Alzheimer’s disease and Parkinson’s disease. Drug Des Devel Ther. 2017;11:797–810. doi:10.2147/DDDT.S130514. PubMed PMID: 28352155; PubMed Central PMCID: PMC5358994.
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Swomley AM, Sultana R. Amyloid beta-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression. Antioxid Redox Signaling. 2013;19(8):823–35. doi:10.1089/ars.2012.5027. PubMed PMID: 23249141; PubMed Central PMCID: PMC3749710.
   PubMed Web of Science ®Google Scholar
• Cui H, Kong Y, Zhang H. Oxidative stress, mitochondrial dysfunction, and aging. J Signal Transduct. 2012;2012:1–13. PubMed PMID: 21977319; PubMed Central PMCID: PMC3184498. doi: 10.1155/2012/646354
   Google Scholar
• Thapa A, Chi EY. Biflavonoids as potential small molecule therapeutics for Alzheimer’s disease. Nat Compd Ther Agents Amyloidogenic Diseases. 2015;863:55–77. PubMed PMID: WOS:000361795900004. doi: 10.1007/978-3-319-18365-7_3
   Google Scholar
• Johnson WM, Wilson-Delfosse AL, Mieyal JJ. Dysregulation of glutathione homeostasis in neurodegenerative diseases. Nutrients. 2012;4(10):1399–440. PubMed PMID: WOS:000310507400004. doi: 10.3390/nu4101399
   PubMed Web of Science ®Google Scholar
• Kim GH, Kim JE, Rhie SJ, Yoon S. The role of oxidative stress in neurodegenerative diseases. Exp Neurobiol. 2015;24(4):325–40. doi:10.5607/en.2015.24.4.325. PubMed PMID: 26713080; PubMed Central PMCID: PMC4688332.
   PubMed Web of Science ®Google Scholar
• Massaad CA. Neuronal and vascular oxidative stress in Alzheimer’s disease. Curr Neuropharmacol. 2011;9(4):662–73. doi:10.2174/157015911798376244. PubMed PMID: 22654724; PubMed Central PMCID: PMC3263460.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang W, Li L, Perry G, Lee HG, Zhu X. Oxidative stress and mitochondrial dysfunction in Alzheimer’s disease. Biochim Biophys Acta. 2014;1842(8):1240–7. doi:10.1016/j.bbadis.2013.10.015. PubMed PMID: 24189435; PubMed Central PMCID: PMC4007397.
   PubMed Web of Science ®Google Scholar
• Gandhi S, Abramov AY. Mechanism of oxidative stress in neurodegeneration. Oxid Med Cell Longevity. 2012;2012:1–11. doi:10.1155/2012/428010. PubMed PMID: 22685618; PubMed Central PMCID: PMC3362933.
   Web of Science ®Google Scholar
• Zhao Y, Zhao B. Oxidative stress and the pathogenesis of Alzheimer’s disease. Oxid Med Cell Longevity. 2013;2013:1–10. PubMed PMID: 23983897; PubMed Central PMCID: PMC3745981.
   Web of Science ®Google Scholar
• Kryscio RJ, Abner EL, Caban-Holt A, Lovell M, Goodman P, Darke AK, et al. Association of antioxidant supplement use and dementia in the prevention of Alzheimer’s disease by Vitamin E and selenium trial (PREADViSE). Jama Neurol. 2017;74(5):567–73. PubMed PMID: WOS:000400838900014. doi: 10.1001/jamaneurol.2016.5778
   PubMed Web of Science ®Google Scholar
• Grimm MO, Mett J, Hartmann T. The impact of vitamin E and other fat-soluble vitamins on Alzheimer’s disease. Int J Mol Sci. 2016;17(11):1785. PubMed PMID: 27792188; PubMed Central PMCID: PMC5133786. doi: 10.3390/ijms17111785
   Web of Science ®Google Scholar
• Zaman Z, Roche S, Fielden P, Frost PG, Niriella DC, Cayley AC. Plasma concentrations of vitamins A and E and carotenoids in Alzheimer’s disease. Age Ageing. 1992;21(2):91–4. PubMed PMID: 1575097. doi: 10.1093/ageing/21.2.91
   PubMed Web of Science ®Google Scholar
• Mangialasche F, Xu W, Kivipelto M, Costanzi E, Ercolani S, Pigliautile M, et al. Tocopherols and tocotrienols plasma levels are associated with cognitive impairment. Neurobiol Aging. 2012;33(10):2282–90. doi:10.1016/j.neurobiolaging.2011.11.019. PubMed PMID: 22192241.
   PubMed Web of Science ®Google Scholar
• da Silva S L, Vellas B, Elemans S, Luchsinger J, Kamphuis P, Yaffe K, et al. Plasma nutrient status of patients with Alzheimer’s disease: systematic review and meta-analysis. Alzheimers Dement. 2014;10(4):485–502. doi:10.1016/j.jalz.2013.05.1771. PubMed PMID: 24144963.
   PubMed Web of Science ®Google Scholar
• Rinaldi P, Polidori MC, Metastasio A, Mariani E, Mattioli P, Cherubini A, et al. Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease. Neurobiol Aging. 2003;24(7):915–9. PubMed PMID: 12928050. doi: 10.1016/S0197-4580(03)00031-9
   PubMed Web of Science ®Google Scholar
• Bourdel-Marchasson I, Delmas-Beauvieux MC, Peuchant E, Richard-Harston S, Decamps A, Reignier B, et al. Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients. Age Ageing. 2001;30(3):235–41. PubMed PMID: 11443025. doi: 10.1093/ageing/30.3.235
   PubMed Web of Science ®Google Scholar
• Grimm MOW, Mett J, Hartmann T. The impact of vitamin E and other fat-soluble vitamins on Alzheimer’s disease. Int J Mol Sci. 2016;17(11):621–623. PubMed PMID: WOS:000388809600019.
   Web of Science ®Google Scholar
• Vatassery GT, Brin MF, Fahn S, Kayden HJ, Traber MG. Effect of high doses of dietary vitamin E on the concentrations of vitamin E in several brain regions, plasma, liver, and adipose tissue of rats. J Neurochem. 1988;51(2):621–3. PubMed PMID: 3392549. doi: 10.1111/j.1471-4159.1988.tb01083.x
   PubMed Web of Science ®Google Scholar
• Wells GSB, O’Connell N, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale for assessing the quality of nonrandomized studies in meta-analyses. Ottawa (ON): Department of Epidemiology and Community Medicine, University of Ottawa; 2009.
   Google Scholar
• Higgins JGS. Cochrane Handbook for systematic reviews of interventions 5.1.0. The Cochrane Collaboration 2011. Available from: www.cochrane-handbook.org.
   Google Scholar
• Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J. 2003;327(7414):557–60. PubMed PMID: WOS:000185283700028. doi: 10.1136/bmj.327.7414.557
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–101. PubMed PMID: 7786990. doi: 10.2307/2533446
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315:629–34. doi: 10.1136/bmj.315.7109.629
   PubMed Web of Science ®Google Scholar
• Zandi PP, Anthony JC, Khachaturian AS, Stone SV, Gustafson D, Tschanz JT, et al. Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements – the Cache County study. Arch Neurol-Chicago. 2004;61(1):82–8. PubMed PMID: WOS:000188050900013. doi: 10.1001/archneur.61.1.82
   PubMed Web of Science ®Google Scholar
• Maxwell CJ, Hicks MS, Hogan DB, Basran J, Ebly EM. Supplemental use of antioxidant vitamins and subsequent risk of cognitive decline and dementia. Dement Geriatr Cogn Disord. 2005;20(1):45–51. doi:10.1159/000085074. PubMed PMID: 15832036.
   PubMed Web of Science ®Google Scholar
• Morris MC, Beckett LA, Scherr PA, Hebert LE, Bennett DA, Field TS, et al. Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Dis Assoc Disord. 1998;12(3):121–6. PubMed PMID: 9772012. doi: 10.1097/00002093-199809000-00001
   PubMed Web of Science ®Google Scholar
• Gray SL, Anderson ML, Crane PK, Breitner JCS, McCormick W, Bowen JD, et al. Antioxidant vitamin supplement use and risk of dementia or Alzheimer’s disease in older adults. J Am Geriatr Soc. 2008;56(2):291–5. PubMed PMID: WOS:000252713300014. doi: 10.1111/j.1532-5415.2007.01531.x
   PubMed Web of Science ®Google Scholar
• Morris MC, Evans DA, Bienias JL, Tangney CC, Bennett DA, Aggarwal N, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA. 2002;287(24):3230–7. PubMed PMID: 12076219. doi: 10.1001/jama.287.24.3230
   PubMed Web of Science ®Google Scholar
• Luchsinger JA, Tang MX, Shea S, Mayeux R. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol-Chicago. 2003;60(2):203–8. PubMed PMID: WOS:000180927900007. doi: 10.1001/archneur.60.2.203
   PubMedGoogle Scholar
• Basambombo LL, Carmichael PH, Cote S, Laurin D. Use of vitamin E and C supplements for the prevention of cognitive decline. Ann Pharmacother. 2017;51(2):118–24. PubMed PMID: WOS:000391772200003. doi: 10.1177/1060028016673072
   PubMed Web of Science ®Google Scholar
• Dysken MW. Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial. JAMA. 2014;311(1):33–44. PubMed PMID: WOS:000333010100031. doi: 10.1001/jama.2013.282834
   PubMed Web of Science ®Google Scholar
• Lloret A, Badia MC, Mora NJ, Pallardo FV, Alonso MD, Vina J. Vitamin E paradox in Alzheimer’s disease: it does not prevent loss of cognition and may even be detrimental. J Alzheimers Dis. 2009;17(1):143–9. PubMed PMID: WOS:000267289200014. doi: 10.3233/JAD-2009-1033
   PubMed Web of Science ®Google Scholar
• Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. The Alzheimer’s disease cooperative study. N Engl J Med. 1997;336(17):1216–22. doi:10.1056/NEJM199704243361704. PubMed PMID: 9110909.
   PubMed Web of Science ®Google Scholar
• Li FJ, Shen L, Ji HF. Dietary intakes of vitamin E, vitamin C, and beta-carotene and risk of Alzheimer’s disease: a meta-analysis. J Alzheimers Dis. 2012;31(2):253–8. PubMed PMID: WOS:000307377300002. doi: 10.3233/JAD-2012-120349
   PubMed Web of Science ®Google Scholar
• Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar EL. Meta-Analysis: high-dosage vitamin E supplementation may increase all-cause mortality. ACC Curr J Rev. 2005;14(5):17. doi:10.1016/j.accreview.2005.04.017.
   Google Scholar
• Ames D, Ritchie C. Antioxidants and Alzheimer’s disease: time to stop feeding vitamin E to dementia patients? Int Psychogeriatr. 2007;19(1):1–8. PubMed PMID: 17310512. doi: 10.1017/S104161020600439X
   PubMed Web of Science ®Google Scholar
• Farina N, Llewellyn D, Isaac MGEN, Tabet N. Vitamin E for Alzheimer’s dementia and mild cognitive impairment. Cochrane Db Syst Rev. 2017;4:CD002854. doi:10.1002/14651858.
   Google Scholar